← ANALYST RATINGS · TIPRANKS

Albemarle (ALB): analyst forecast and price target

$95.48 −2.75% close 16.10.26 · market cap $11.6B · Basicmaterials · Chemicals - Specialty SPY 0.02%
Price targets and ratings of

Analyst consensus

Moderate Buy

11 Buy4 Hold0 Sell

Ratings of 15 analysts in the last 3 months

12-month forecast

$162+70.0% upside

Based on 15 price targets given in the last 3 months, the average target is $162, the highest $225, the lowest $109. The average is +70.0% from the last price of $95.48.

$100$150$200Jan 26AprJulOctJan 27AprJulOctHigh$225Average$162Low$109
Highest target $225 Average target $162 Lowest target $109
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Arun Viswanathan★★★★★★★★★★#4725 · hits 54% · avg +1.5% RBC Capital $157 → $129−17.8% Buy +35.1% Reiterated 15.10.26on TipRanks 09:30 −0.1%next day −1.6%
John Roberts CFA★★★★★★★★★★#651 · hits 62% · avg +10.3% Mizuho Securities $130 Buy +36.2% Upgrade 13.10.26on TipRanks 17:55 +1.4%next day −0.1%
Unknown Analyst Barclays $109 Hold +14.2% Initiated 12.10.26on TipRanks Oct 13 17:55 −2.7%next day −0.9%
Vincent Andrews★★★★★★★★★★#3768 · hits 62% · avg +2.7% Morgan Stanley $161 Hold +68.6% Reiterated 07.10.26on TipRanks 06:16 −3.1%next day −0.2% · 5 days −3.7%
Bill Selesky★★★★★★★★★★#1503 · hits 60% · avg +7.8% Argus Research $230 → $135−41.3% Buy +41.4% Reiterated 06.10.26on TipRanks Oct 7 08:10 +1.3%next day −3.1% · 5 days −8.0%
Joel Jackson★★★★★★★★★★#1004 · hits 59% · avg +10.5% BMO Capital $200 → $175−12.5% Buy +83.3% Reiterated 06.10.26on TipRanks 08:01 +1.3%next day −3.1% · 5 days −8.0%
Joshua Spector★★★★★★★★★★#3207 · hits 53% · avg +3.3% UBS $175 → $150−14.3% Buy +57.1% Reiterated 05.10.26on TipRanks 05:55 −0.9%next day +1.3% · 5 days −6.0%
John Roberts CFA★★★★★★★★★★#651 · hits 62% · avg +10.3% Mizuho Securities $140 → $130−7.1% Hold +36.2% Reiterated 30.09.26on TipRanks Oct 1 07:30 −1.5%next day −0.9% · 5 days −4.8%
John Roberts CFA★★★★★★★★★★#651 · hits 62% · avg +10.3% Mizuho Securities $160 → $140−12.5% Hold +46.6% Reiterated 23.09.26on TipRanks 08:15 −2.1%next day −4.5% · 5 days −6.1%
Laurence Alexander★★★★★★★★★★#5965 · hits 50% · avg +0.8% Jefferies $211 Buy +121.0% Reiterated 11.09.26on TipRanks 10:26 −4.3%next day −1.7% · 5 days −5.5%
Jeffrey Zekauskas★★★★★★★★★★#2991 · hits 53% · avg +3.3% J.P. Morgan $160 → $140−12.5% Hold +46.6% Assigned 25.08.26on TipRanks 08:10 −6.2%next day +1.0% · 5 days +2.3%
Tina Ting Hu★★★★★★★★★★#2594 · hits 45% · avg +25.8% DBS $170 Buy +78.0% Reiterated 20.08.26on TipRanks Aug 24 03:35 +0.8%next day +6.3% · 5 days +0.1%
Pete Osterland★★★★★★★★★★#1396 · hits 60% · avg +19.4% Truist Financial $225 Buy +135.7% Reiterated 11.08.26on TipRanks Aug 12 22:25 −1.1%next day −1.0% · 5 days +3.0%
Ben Isaacson★★★★★★★★★★#2733 · hits 49% · avg +6.0% Scotiabank $200 → $190−5.0% Buy +99.0% Reiterated 10.08.26on TipRanks 07:45 +0.1%next day −1.1% · 5 days +2.2%
Vincent Andrews★★★★★★★★★★#3768 · hits 62% · avg +2.7% Morgan Stanley $189 → $161−14.8% Hold +68.6% Assigned 10.08.26on TipRanks 07:07 +0.1%next day −1.1% · 5 days +2.2%
Arun Viswanathan★★★★★★★★★★#4725 · hits 54% · avg +1.5% RBC Capital $166 → $157−5.4% Buy +64.4% Reiterated 07.08.26on TipRanks Aug 10 07:25 +3.9%next day +0.1% · 5 days +3.4%
Eric Boyes★★★★★★★★★★#5799 · hits 57% · avg +3.2% Evercore ISI $180 Hold +88.5% Reiterated 07.08.26on TipRanks 13:07 +3.9%next day +0.1% · 5 days +3.4%
Joshua Spector★★★★★★★★★★#3207 · hits 53% · avg +3.3% UBS $205 → $175−14.6% Buy +83.3% Assigned 07.08.26on TipRanks 09:07 +3.9%next day +0.1% · 5 days +3.4%
Joel Jackson★★★★★★★★★★#1004 · hits 59% · avg +10.5% BMO Capital $250 → $200−20.0% Buy +109.5% Reiterated 07.08.26on TipRanks 08:06 +3.9%next day +0.1% · 5 days +3.4%
Patrick Cunningham★★★★★★★★★★#4783 · hits 54% · avg +2.3% Citi $225 → $175−22.2% Buy +83.3% Reiterated 07.08.26on TipRanks 07:01 +3.9%next day +0.1% · 5 days +3.4%
Matthew DeYoe★★★★★★★★★★#2749 · hits 62% · avg +7.2% Bank of America Securities $155 Buy +62.3% Reiterated 07.08.26on TipRanks 04:50 +3.9%next day +0.1% · 5 days +3.4%
Michael Sison★★★★★★★★★★#11471 · hits 43% · avg −2.5% Wells Fargo $200 Hold +109.5% Reiterated 04.06.26on TipRanks Jun 5 05:40 −2.0%next day −3.6% · 5 days −1.4%
Andres Castanos-Mollor★★★★★★★★★★#10808 · hits 39% · avg −3.9% Berenberg Bank $153 → $192+25.5% Hold +101.1% Reiterated 02.06.26on TipRanks Jun 3 01:30 +0.2%next day −1.3% · 5 days −8.1%
Kevin McCarthy★★★★★★★★★★#3631 · hits 61% · avg +7.5% Vertical Research $224 Buy +134.6% Upgrade 26.05.26on TipRanks 07:11 +1.1%next day +1.6% · 5 days −2.9%
David Begleiter★★★★★★★★★★#4870 · hits 52% · avg +1.4% Deutsche Bank $210 → $250+19.0% Buy +161.8% Reiterated 12.05.26on TipRanks 21:20 −2.8%next day −5.7% · 5 days −15.1%
Bill Selesky★★★★★★★★★★#1503 · hits 60% · avg +7.8% Argus Research $185 → $230+24.3% Buy +140.9% Assigned 11.05.26on TipRanks 08:55 +3.0%next day −2.0% · 5 days −16.2%
Ben Kallo★★★★★★★★★★#2316 · hits 43% · avg +6.2% Robert W. Baird $210 → $236+12.4% Hold +147.2% Reiterated 08.05.26on TipRanks 09:00 +1.8%next day +3.0% · 5 days −11.6%
Mazahir Mammadli★★★★★★★★★★#9219 · hits 33% · avg −2.8% Rothschild & Co Redburn $185 → $188+1.6% Hold +96.9% Downgrade 22.04.26on TipRanks 04:50 −3.1%next day −0.2% · 5 days −1.8%
Ishan Jain★★★★★★★★★★#10729 · hits 0% · avg −31.0% HSBC $200 Buy +109.5% Upgrade 18.01.26on TipRanks Jan 19 14:40 +7.9%next day +3.2% · 5 days +9.9%
Aleksey Yefremov★★★★★★★★★★#1445 · hits 57% · avg +7.5% KeyBanc — Hold — Reiterated 07.11.25on TipRanks 07:40 +6.4%next day +5.0% · 5 days +18.3%
David Deckelbaum★★★★★★★★★★#1693 · hits 49% · avg +10.0% TD Cowen $85.00 Hold −11.0% Reiterated 05.11.25on TipRanks 23:10 +0.3%next day +6.4% · 5 days +25.3%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Albemarle

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months David Begleiter★★★★★★★★★★Deutsche Bank · #4870
Hits 52%250 of 481 Average return +1.4%
1 year Joel Jackson★★★★★★★★★★BMO Capital · #1004
Hits 59%187 of 317 Average return +10.5%
2 years Arun Viswanathan★★★★★★★★★★RBC Capital · #4725
Hits 54%268 of 498 Average return +1.5%

Most profitable

3 months Joel Jackson★★★★★★★★★★BMO Capital · #1004
Hits 59%187 of 317 Average return +10.5%
1 year Joel Jackson★★★★★★★★★★BMO Capital · #1004
Hits 59%187 of 317 Average return +10.5%
2 years Joel Jackson★★★★★★★★★★BMO Capital · #1004
Hits 59%187 of 317 Average return +10.5%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $175 at a price of $106 (+65.0%); now: $162 at $95.48 (+70.0%).

$100$125$150$175Sep 15Oct 1Oct 15Top analysts$158Average target$162Price$95.48

PriceAverage targetTop analysts’ target

Recommendation trend

020408142Oct 2510212Nov11292Dec18261Jan 262023Feb1917Mar1416Apr1614May11516Jun31212Jul6910Aug688Sep5109Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy013665
Buy1615129810
Hold1416121089
Sell000000

Earnings and sales forecast

Next report: 04.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $2.58 (from $1.81 to $3.40). Last quarter: $3.75.

Sales

Next quarter’s sales estimate — $1.5B (from $1.4B to $1.7B). Last quarter: $1.7B.

Best top-analyst consensus in the sector · Basicmaterials

HBMnot in our ETFs
KGCnot in our ETFs
USARUSA Rare Earth
SSRMSSR Mining
EQXnot in our ETFs
About Albemarle
  • CEO: Jerry Kent Jr.
  • Employees: 7,800
  • 4250 Congress Street, Charlotte, NC, 28209, US
  • www.albemarle.com

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Establis

Data from the stock’s TipRanks forecast page, read 14 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗